Cardiovascular Pharmacology, 3rd Edition - N1744


About Course #N1744

Release Date: December 27, 2016

Expiration Date: December 31, 2019

According to data from the Center for Disease Control, 610,000 people die from heart disease in the United States annually. One in every four deaths is due to cardiovascular disease. There are also 12 million yearly visits to physician's offices and close to 4 million hospital discharges for cardiovascular disease. Treatment of cardiovascular disease and monitoring for therapeutic efficacy and side effects of the drugs used require a sound knowledge of the pharmacology of these agents.

Ongoing education is needed to keep pace with these evolving changes and to equip nursing professionals with the necessary knowledge and skills to implement the most recent advances in treatment. Nurses have an important responsibility in caring for patients who are receiving these medications. Knowledge of cardiovascular medications, their effects on the body, and their administration; assessment of therapeutic and adverse effects; and patient education are essential. The purpose of this course is to provide an overview of cardiovascular pharmacology. With an ever-increasing number of patients living longer, quality nursing care for those receiving drugs for cardiovascular disease will make this knowledge critical.

Kentucky APRNs - fulfills pharmacology requirement

About the Author(s)

David S. Roffman, BS Zoology, BS Pharmacy, PharmD, BCPS, AQ Cardiology, is professor emeritus at the School of Pharmacy, University of Maryland. Dr. Roffman taught much of the cardiovascular therapeutics curriculum in both the didactic and experiential portions of the curriculum during his 45-year tenure at the school. He was recognized as Teacher of the Year on six occasions by students or faculty at the school, and in 2010, he was honored as Teacher of the Year for Founders Week at the University of Maryland Baltimore Campus. In addition to his efforts at the School of Pharmacy, Dr. Roffman taught in the Cardiology Module of the Pathophysiology, Pharmacology, and Therapeutics course at the University of Maryland School of Medicine as well as the Nursing Pharmacology course at the School of Nursing. He served as the therapeutic consultant to the Cardiac Care Unit and the Progressive Care Cardiac Unit at the University of Maryland Medical System for more than 40 years. Dr. Roffman was one of the original 17 specialty cardiology pharmacy practitioners in the United States to receive added qualifications in cardiology by the Board of Pharmacy Specialties.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.

  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 91.94ms
  • bvseo-msg: HTTP status code of 404 was returned;